See also this year's filing and all EDGAR filings for this company.
PDF Report 0001719406_2025_NRX_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001719406, NRX Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,302,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 349,000 |
| 4 | LiabilitiesCurrent | 21,863,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,011,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,505,000 |
| 9 | ResearchAndDevelopmentExpense | 6,199,000 |
| 10 | remainder_Expenses | -1,202,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -6,624,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,651,000 |
| 1 | Liabilities | 26,874,000 |
| 2 | Expenses | 18,502,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -23,223,000 |
| 5 | NetIncome | -25,126,000 |
| 6 | ComprehensiveNetIncome | -25,126,000 |
| 7 | BaseVar | 27,825,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.96 |
| 9 | EconomicCapitalRatio | 0.197 |
Edgar->Model Mapping
Feature Distribution
Change over Time
